Medical Library | Shanghai Healthy Aging and Clinical Innovation Series
Fudan University Huadong Hospital is a major Shanghai center for geriatric medicine and complex care in older adults. Its programs connect cardiovascular devices, heart-failure imaging, orthopedic robotics, osteoporosis and fracture management, frailty research, and integrative medicine.
This Medical Library review summarizes three representative teams and the 2025–2026 progress provided. The central theme is healthy aging: using less invasive devices, better risk markers, complete fracture pathways, and evidence-informed integrative care to support older patients with multiple chronic conditions.
1. Cardiovascular Medicine: Smaller Devices and Imaging Markers for Older Patients
Lead: Professor Qu Xinkai
Focus: Bradycardia and pacing in older adults, heart failure with preserved ejection fraction (HFpEF), and age-sensitive cardiovascular care.
Older patients often have several competing risks at once: conduction disease, frailty, kidney dysfunction, bleeding risk, diabetes, and reduced tolerance for major surgery. The cardiovascular program at Huadong Hospital is described as focusing on small-device intervention and imaging-based risk assessment.
Key 2025–2026 milestones
- Atrial leadless pacing: The team was among the first groups in China to implant an atrial leadless pacemaker in December 2025.
- HFpEF imaging marker: Intermuscular adipose tissue density was reported at ACC.26 in April 2026 as a sex-specific prognostic marker for HFpEF.
Leadless pacing can reduce some complications associated with conventional transvenous leads and pockets, but patient selection remains important. The appropriate device depends on the type of conduction disorder, atrial and ventricular function, need for future pacing, anatomy, infection risk, and the availability of follow-up programming.
In HFpEF, imaging markers involving muscle and fat may help describe frailty, body composition, inflammation, and prognosis. A research marker should not be treated as a standalone diagnosis. Patients should ask whether the measurement changes treatment, how it was validated, and how it fits with echocardiography, kidney function, exercise tolerance, blood pressure, and comorbidity management.
For broader patient background, see our Heart Valve Disease Treatment in Shanghai Medical Library guide.
Clinical profile: A geriatric-centered cardiovascular program combining miniature devices with imaging-based risk stratification.
2. Orthopedics and Osteoporosis: Robotic Surgery with a Full-Cycle Fracture Pathway
Lead: Professor Bao Zhijun, President of Huadong Hospital
Focus: Fragility fractures in older adults, osteoporotic vertebral fractures, sarcopenia, and orthopedic robotics.
In older adults, a fracture is rarely an isolated orthopedic event. It can trigger immobility, muscle loss, pneumonia, blood clots, loss of independence, and worsening osteoporosis. Effective treatment therefore requires more than fixing the bone. It includes fall-risk assessment, pain control, nutrition, muscle strengthening, osteoporosis medication, home safety, and long-term follow-up.
Key 2025–2026 milestone
The MAKO orthopedic surgical robot entered clinical use at the hospital in August 2026. The program also emphasizes full-cycle management for older patients with fractures, linking acute surgery with rehabilitation, sarcopenia assessment, osteoporosis treatment, and prevention of a second fracture.
Robotic assistance may improve planning and alignment for selected joint procedures, but it is not automatically better for every patient. The decision depends on the joint involved, deformity, bone quality, surgical risk, functional goals, and surgeon experience. Older patients should ask how the robot changes the operation, what recovery is expected, and how osteoporosis and frailty will be treated at the same time.
For vertebral compression fractures, the key questions include whether the fracture is acute, whether there is spinal-cord or nerve compression, whether bone density has been assessed, and whether vertebral augmentation, conservative treatment, or another procedure is appropriate.
Clinical profile: A geriatric orthopedic model combining robotic precision with fracture prevention, rehabilitation, and long-term bone-health management.
3. Integrative Medicine and Geriatric Frailty: Turning Community Data into Evidence
Leads: Professors Chen Chuan and Wu Tao
Focus: Frailty in older adults, chronic multimorbidity, and evidence-based traditional Chinese medicine.
Frailty is a state of reduced physiological reserve. It may involve weakness, slow walking, unintentional weight loss, exhaustion, cognitive decline, poor nutrition, and increased vulnerability to small illnesses or procedures. Frailty is not simply the same as age, and it can sometimes improve when contributing factors are identified.
Key 2025–2026 milestones
- Community epidemiology: A study of 3,725 older adults examined the prevalence and characteristics of frailty in the community.
- Continuing education: A National Administration of Traditional Chinese Medicine continuing-education program was reported in August 2026.
Large community studies can help identify who is most at risk and which combinations of nutrition, exercise, medication review, social support, and medical treatment may be useful. The next challenge is translating population findings into individualized care plans that are safe for patients with multiple medications and chronic diseases.
Integrative care should be transparent about evidence. Patients should ask which treatment is being used, what the expected benefit is, whether it may interact with prescription medicines, and how outcomes will be measured. TCM approaches may complement conventional care, but they should not replace urgent evaluation, evidence-based surgery, pacemaker assessment, fracture treatment, or heart-failure management.
Our Geriatric Medicine at Huadong Hospital article provides related background. Patients interested in the wider Shanghai TCM system may also consult this TCM patient guide.
Clinical profile: A large-scale community and integrative-medicine program aiming to make geriatric frailty care more evidence-based and more connected to daily life.
4. Why Healthy Aging Requires More Than One Department
The three Huadong Hospital programs address different but connected risks:
- Cardiovascular risk: bradycardia, pacing needs, HFpEF, and reduced physiological reserve.
- Musculoskeletal risk: osteoporosis, fracture, sarcopenia, immobility, and loss of independence.
- Geriatric risk: frailty, multimorbidity, polypharmacy, nutrition, cognition, and social support.
For an older patient, a successful operation or device implant is only one part of the outcome. The care plan should also address mobility, medication safety, kidney function, cognition, nutrition, rehabilitation, caregiver capacity, and the ability to return safely home.
5. How CMCS Helps International Older Patients and Families Communicate with Specialists
For an international older patient seeking cardiovascular, orthopedic, geriatric, or integrative care in Shanghai, the most useful first step is to present the complete medical picture rather than a single symptom. China Medical Concierge Shanghai (CMCS) is a health management and medical coordination service that helps patients connect with specialist doctors and hospital resources in Shanghai. CMCS is not a hospital and does not independently diagnose or prescribe treatment.
Before a consultation, CMCS can help organize ECG and echocardiography, imaging, bone-density tests, fracture records, kidney function, medication lists, fall history, mobility assessments, nutrition information, cognitive symptoms, previous operations, and the family's care priorities. For overseas patients, these records can be arranged into a concise English medical summary for the specialist.
CMCS can help families prepare focused questions such as:
- Is a leadless pacemaker appropriate for this patient's exact rhythm disorder and future pacing needs?
- What does the HFpEF imaging marker add beyond echocardiography and standard clinical assessment?
- Would robotic orthopedic surgery provide a meaningful benefit for this patient's anatomy, bone quality, and functional goals?
- How will osteoporosis, sarcopenia, fall risk, nutrition, and rehabilitation be managed after a fracture?
- Does the patient meet criteria for frailty, and which factors may be reversible?
- Could a TCM or integrative treatment interact with anticoagulants, heart medicines, diabetes drugs, or osteoporosis therapy?
- What follow-up, caregiver support, home equipment, and emergency plan will be required?
During the consultation, CMCS can assist with appointment coordination, medical interpretation, communication between the patient and the care team, and clarification of the doctor's recommendations. Afterward, a case manager can help organize the proposed next steps, identify additional records or tests, clarify the follow-up schedule, and coordinate further communication with the hospital.
The final treatment decision must be made by the patient and the treating medical team. CMCS does not independently select a device, operation, medicine, or integrative treatment. Its role is to help the patient and family bring complete information to the right specialist and ensure that evidence, risks, alternatives, access, and long-term monitoring are discussed clearly.
To learn more about specialist consultations and treatment coordination in Shanghai, contact CMCS:
Email: contract@medicalsh.com
WhatsApp: Contact CMCS on WhatsApp
Website: medicalsh.com
Conclusion
The Huadong Hospital teams reviewed here illustrate a practical model of healthy aging: smaller cardiovascular devices, imaging-based risk assessment, robotic orthopedic surgery, complete fracture pathways, community frailty research, and integrative care for older adults with multiple chronic conditions.
For older patients, the best outcome is not always the most technologically complex intervention. It is the plan that improves safety, independence, comfort, and long-term function while fitting the patient's health status and personal goals. This article was prepared from the team and program information provided for editorial use. Research findings, device availability, clinical recommendations, and treatment access should be confirmed through the hospital, research team, regulatory authorities, and formally published studies. This article is for medical education only and is not individualized medical advice.
0件のコメント